Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linqi Zhang

Showing results (251-260 of 279) with videos related to

Pageof 28
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2026
Decoding antibody response to MERS-CoV in wild dromedary camelsFaten Idoudi, Ruoke Wang, Long Tian, et al.
Cell Reports. Medicine|March 10, 2026
Identification and characterization of bone marrow plasma cells producing IFN-γ-neutralizing autoantibodies in adult-onset immunodeficiencyHan Wang, Qianqian Yang, Tian Zhao, et al.
Cell Reports. Medicine|November 1, 2021
A pathogen-like antigen-based vaccine confers immune protection against SARS-CoV-2 in non-human primatesChang Guo, Yanan Peng, Lin Lin, et al.
Chembiochem : a European Journal of Chemical Biology|September 20, 2024
Discovery of <sup>18</sup>F Labeled AZD5213 Derivatives as Novel Positron Emission Tomography (PET) Radioligands Targeting Histamine Subtype-3 ReceptorZhendong Song, Yinlong Li, Kenneth Dahl, et al.
Nature|May 27, 2020
Human neutralizing antibodies elicited by SARS-CoV-2 infectionBin Ju, Qi Zhang, Jiwan Ge, et al.
Nature Immunology|March 14, 2023
Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariantsBin Ju, Qi Zhang, Ziyi Wang, et al.
Plos Pathogens|November 11, 2024
Super broad and protective nanobodies against Sarbecoviruses including SARS-CoV-1 and the divergent SARS-CoV-2 subvariant KP.3.1.1Haodi Dong, Runhong Zhou, Jing Chen, et al.
Cell Discovery|September 8, 2022
Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineagesXiaoman Li, Yongbing Pan, Qiangling Yin, et al.
Signal Transduction and Targeted Therapy|May 7, 2021
HLA-mismatched allogeneic adoptive immune therapy in severely immunosuppressed AIDS patientsRuonan Xu, Ji-Yuan Zhang, Bo Tu, et al.
JCI Insight|June 15, 2017
Delineating antibody recognition against Zika virus during natural infectionLei Yu, Ruoke Wang, Fei Gao, et al.
Pageof 28

Showing results (251-260 of 279) with videos related to

Sort By:
Pageof 28
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2026
Decoding antibody response to MERS-CoV in wild dromedary camelsFaten Idoudi, Ruoke Wang, Long Tian, et al.
Cell Reports. Medicine|March 10, 2026
Identification and characterization of bone marrow plasma cells producing IFN-γ-neutralizing autoantibodies in adult-onset immunodeficiencyHan Wang, Qianqian Yang, Tian Zhao, et al.
Cell Reports. Medicine|November 1, 2021
A pathogen-like antigen-based vaccine confers immune protection against SARS-CoV-2 in non-human primatesChang Guo, Yanan Peng, Lin Lin, et al.
Chembiochem : a European Journal of Chemical Biology|September 20, 2024
Discovery of <sup>18</sup>F Labeled AZD5213 Derivatives as Novel Positron Emission Tomography (PET) Radioligands Targeting Histamine Subtype-3 ReceptorZhendong Song, Yinlong Li, Kenneth Dahl, et al.
Nature|May 27, 2020
Human neutralizing antibodies elicited by SARS-CoV-2 infectionBin Ju, Qi Zhang, Jiwan Ge, et al.
Nature Immunology|March 14, 2023
Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariantsBin Ju, Qi Zhang, Ziyi Wang, et al.
Plos Pathogens|November 11, 2024
Super broad and protective nanobodies against Sarbecoviruses including SARS-CoV-1 and the divergent SARS-CoV-2 subvariant KP.3.1.1Haodi Dong, Runhong Zhou, Jing Chen, et al.
Cell Discovery|September 8, 2022
Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineagesXiaoman Li, Yongbing Pan, Qiangling Yin, et al.
Signal Transduction and Targeted Therapy|May 7, 2021
HLA-mismatched allogeneic adoptive immune therapy in severely immunosuppressed AIDS patientsRuonan Xu, Ji-Yuan Zhang, Bo Tu, et al.
JCI Insight|June 15, 2017
Delineating antibody recognition against Zika virus during natural infectionLei Yu, Ruoke Wang, Fei Gao, et al.
Pageof 28